Henric Blomgren
#139,210
Most Influential Person Now
Henric Blomgren's AcademicInfluence.com Rankings
Henric Blomgrenmedical Degrees
Medical
#2474
World Rank
#2901
Historical Rank
Oncology
#154
World Rank
#160
Historical Rank
Henric Blomgrenphilosophy Degrees
Philosophy
#7187
World Rank
#10360
Historical Rank
Logic
#4257
World Rank
#5527
Historical Rank
Download Badge
Medical Philosophy
Why Is Henric Blomgren Influential?
(Suggest an Edit or Addition)Henric Blomgren's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. (1995) (849)
- Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. (1994) (549)
- Cancer risks in patients with chronic lymphocytic thyroiditis. (1985) (523)
- Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. (1992) (481)
- Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. (2002) (268)
- Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. (1971) (256)
- Evidence for a small pool of immunocompetent cells in the mouse thymus. (1969) (254)
- Characteristics of the immunocompetent cells in the mouse thymus: cell population changes during cortisone-induced atrophy and subsequent regeneration. (1970) (238)
- Radiosurgery for Tumors in the Body: Clinical Experience Using a New Method (1998) (219)
- Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma (2006) (216)
- Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. (2005) (202)
- Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? (1994) (179)
- A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma (2006) (166)
- CELLS MEDIATING SPECIFIC IN VITRO CYTOTOXICITY (1972) (165)
- Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon (1978) (142)
- Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. (2000) (133)
- Evidence for a small pool of immunocompetent cells in the mouse thymus. Its role in the humoral antibody response against sheep erythrocytes, bovine serum albumin, ovalbumin and the NIP determinant. (1970) (120)
- Anaplastic Giant Cell Carcinoma of the Thyroid Gland: Treatment and Survival Over a 25-Year Period (1998) (118)
- Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. (1975) (102)
- In vitro stimulation of mouse thymus cells by PHA and allogeneic cells. (1971) (99)
- Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. (2000) (98)
- Extracranial Stereotactic Radiosurgery of Localized Targets (1998) (96)
- Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity: efficiency of very small amounts of highly purified T cells. (1973) (89)
- Interferon and spontaneous cytotoxicity in man. II. Studies in patients receiving exogenous leukocyte interferon. (2009) (89)
- Long-term Results after Fractionated Radiation Therapy for Large Brain Arteriovenous Malformations (2005) (78)
- Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon (1980) (78)
- Blood lymphocytes after radiation therapy of mammary carcinoma. (1974) (76)
- Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. (1985) (74)
- Effect of Human Leukocyte Interferon on the Response of Lymphocytes to Mitogenic Stimuli In Vitro (1974) (72)
- Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon‐induced enhancement of natural killer activity and clinical response to human interferon‐α (1982) (68)
- Strong Stimulation of CBA Lymphocytes in the Mixed Lymphocyte Interaction with Cells from the H‐2‐Identical Strain C3H (1974) (65)
- Interferon therapy in Hodgkin's disease. A case report. (2009) (65)
- The effect of irradiation on T-cell suppression of ELISA-determined Ig production by human blood B-cells in vitro. (1979) (57)
- Effect of radiotherapy on blood lymphocyte population in mammary carcinoma. (1976) (56)
- Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies. (1997) (53)
- Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery. (1990) (51)
- Blood lymphocyte subpopulations in breast cancer patients following radiotherapy. (1977) (51)
- Stereotactic radiation therapy of intracranial lesions. Methodologic aspects. (1986) (50)
- Uptake of Adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas (1990) (48)
- On T-cell-mediated cytotoxicity. (1973) (47)
- Steroid Sensitivity of the Response of Human Lymphocytes to Phytohemagglutinin and Pokeweed Mitogen: Role of Phagocytic Cells (1974) (47)
- Specific cytotoxicity by sensitized mouse thymus cells on tissue culture target cells. (1970) (47)
- Evidence for thymic dependence of PHA-reactive cells in spleen and lymph nodes and independence in bone marrow. (1971) (46)
- Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr‐release assay (1977) (45)
- Trait Anxiety and Anticipatory Immune Reactions in Women Receiving Adjuvant Chemotherapy for Breast Cancer (1993) (45)
- Immunosuppression in irradiated breast cancer patients: in vitro effect of cyclooxygenase inhibitors. (1989) (45)
- Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy (1981) (42)
- A retrospective study of SBRT of metastases in patients with primary sarcoma (2012) (41)
- Stereotactic radiation therapy of intracranial arteriovenous malformations. (1986) (41)
- Role of B Cells in the Expression of the PPD Response of Human Lymphocytes In Vitro (1975) (40)
- Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells (1985) (37)
- Blood lymphocytes in breast cancer patients following radiotherapy and surgery. (1977) (35)
- Stereotactic Radiotherapy of Extracranial Targets (1994) (35)
- Specific adsorption of cytotoxic thymus‐processed lymphocytes (T cells) on glutaraldehyde‐fixed fibroblast monolayers (1972) (33)
- Characterization of mouse cells releasing or responding to mitogenic factor induced by phytomitogens in vitro. (1975) (33)
- Lymphocyte‐mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls (1980) (32)
- Disappearance of Specifically MLC‐Responsive Lymphocytes in CBA Mice Injected with Cells from the H‐2‐Compatible, M‐Antigen‐Incompatible Strain C3H (1975) (32)
- Evidence for the appearance of non-specific suppressor cells in the blood after local radiation therapy. (1978) (31)
- Cellular composition of mouse thymus after x-ray exposure. (1968) (30)
- Changes of the PHA-responding pool of cells in the thymus after cortisone or x-ray treatment of mice. Evidence for an invese relation between the production of cortical and medullary thymocytes. (1972) (29)
- Impaired lymphocyte responses to PPD-tuberculin in advanced breast carcinoma. Increased reactivity after depletion of phagocytic or adherent cells. (1976) (29)
- T lymphocyte subpopulations in blood following radiation therapy for breast cancer. (1982) (28)
- Modification of the Response of Human T Lymphocytes to Phytomitogens by Cocultivation with Unresponsive Non‐T Leukocytes (1976) (28)
- Natural killer activity in peripheral lymphocyte population following local radiation therapy. (1980) (28)
- Responses of mouse thymic cells to mitogens. A comparison between phytohaemagglutinin and concanavalin A. (1974) (27)
- Blood lymphocytes after radiation therapy of carcinoma of prostate and urinary bladder. (1974) (27)
- Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information. (2005) (27)
- Distribution of lymphocyte subsets following radiation therapy directed to different body regions. (1983) (27)
- Inhibition of erythroid cell growth in irradiated mice by allogeneic lymphoid cells: a quantitative method for graft-versus-host-reactivity of lymphoid cells. (1972) (27)
- Recirculating lymphocytes in the mouse thymus are part of the relatively cortisone resistant cell population. (1972) (26)
- Radiosurgery for recurring liver metastases after hepatectomy. (2003) (26)
- Studies on the proliferation of thymus cells injected into syngeneic or allogeneic irradiated mice. (1971) (26)
- Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes. (2009) (26)
- Specifically Decreased MLC Response of Lymphocytes from CBA Mice Injected with Cells from the H‐2‐Compatible, M‐Antigen‐Incompatible Strain C3H (1975) (24)
- Steroid sensitivity of the PHA and PWM responses of fractionated human lymphocytes in vitro. (1976) (23)
- Growth inhibition of human malignant glioma cells in vitro by agents which interfere with biosynthesis of eicosanoids. (1992) (23)
- Social support and immune status during and after chemotherapy for breast cancer. (1996) (23)
- Increased granulocyte phagocytosis after oral administration of bestatin, a new immunomodulator. (1982) (23)
- Cytokine release from mononuclear cells in patients irradiated for breast cancer. (1991) (23)
- Changes of the peripheral lymphocyte population following radiation therapy to extended and limited fields. (1979) (23)
- Effect of radiation therapy and in vitro x-ray exposure on lymphocyte subpopulations and their functions. (1982) (22)
- Reductions of responder and stimulator capacities of peripheral lymphoid cells in the mixed lymphocyte culture following external radiotherapy. (1977) (22)
- T helper/suppressor ratios in chemotherapy and radiotherapy. (1983) (22)
- The effect of bone marrow protection on the cellular composition of irradiated mouse thymus. (1968) (21)
- 2175 Radiosurgery for tumors in the body (1997) (21)
- Response of human lymphocytes to mitogenic stimuli after irradiation in vitro. (1976) (20)
- Lymphocyte populations in peripheral blood in hyperthyroid and euthyroid subjects. (1976) (20)
- Radiosensitivity of T-lymphocyte subpopulations. (1982) (20)
- High dose rDNA human alpha 2 interferon therapy in patients with advanced colorectal adenocarcinoma: a phase II study. (1984) (19)
- Monocyte release and plasma levels of interleukin-6 in patients irradiated for cancer. (1992) (19)
- Adjuvant interferon treatment of human osteosarcoma. (1982) (19)
- Lymphopenia and metastatic breast cancer patients with and without radiation therapy. (1976) (19)
- T-cell response to polyvinyl pyrrolidone is linked to maturity of B cells (1975) (19)
- Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma. (1995) (19)
- Autonomy of thymus‐processed lymphocytes (T cells) for their education into cytotoxic cells (1972) (18)
- Changes in mixed lymphocyte culture (MLC) functions of peripheral lymphoid cells after radiation therapy for breast carcinoma. (1979) (18)
- Effect of an intramuscular injection of human leukocyte interferon on blood leukocyte counts and proportions of lymphocytes forming E, EA and EAC rosettes. (1980) (17)
- Lymphokine production by PHA-stimulated human lymphocytes is enhanced by interferon. (1981) (17)
- Anticipatory immune changes in women treated with chemotherapy for ovarian cancer (1995) (17)
- Effects of some prostaglandins and leukotrienes on lymphocytes, monocytes and their activity in vitro. (1987) (17)
- In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens. (1983) (17)
- The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme (2005) (17)
- Changes of blood T cell subsets following radiation therapy for breast cancer. (1983) (17)
- Evidence for the Release of Mitogenic Factors by Both T and B Lymphocytes in the Human (1976) (16)
- Possible role of acrolein in 4-hydroperoxycyclophosphamide-induced cell damage in vitro. (1991) (16)
- Evidence that Soluble Products Released by PHA‐stimulated Human Lymphoid Cells Activate Immunosuppressive Monocytes (1979) (16)
- Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy. (1979) (16)
- Effect of tamoxifen on pokeweed mitogen stimulated immunoglobulin secretion in vitro. (1986) (16)
- Interferon and spontaneous cytotoxicity in man. III. Effect of interferon on lymphocytes and target cells in vitro. (1979) (15)
- Evidence for a loss of recirculating capacity of T-cells after antigenic stimulation. (1973) (15)
- THE INFLUENCE OF BESTATIN ON THE LYMPHOID SYSTEM IN THE HUMAN (1981) (15)
- Curative stereotactic body radiotherapy for liver malignancy (2009) (14)
- Long-term effects on the immune system following local radiation therapy for breast cancer. 4. Proliferative responses and induction of suppressor activity of the blood lymphocyte population. (1986) (14)
- Synergistic enhancement of mitogen responses of human lymphocytes by inhibitors of cyclo-oxygenase and 5,8,11-eicosatriynoic acid, an inhibitor of 12-lipoxygenase and leukotriene biosynthesis. (1987) (14)
- Synergism between thymocytes and lymph node cells in the graft-verses-host response effect of cortisone treatment of the thymus cell donor. (1973) (14)
- Indomethacin modulation of monocyte cytokine release following pelvic irradiation for cancer. (1991) (13)
- Induction of tolerance against the MLs antigen in mice: no need for MLs-bearing cells. (1977) (13)
- The influence of the bone marrow on the repopulation of the thymus in x-irradiated mice. (1969) (13)
- The effect of in vitro irradiation on PHA-mediated cytotoxicity and lymphocytes with receptors for the Fc part of Ig. (1979) (13)
- Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis (1985) (13)
- Prognostic relevance of immunologic variables in breast carcinoma. (1977) (13)
- Possible role of prostaglandin producing monocytes in the depression of mitogenic responses of blood lymphocytes following radiation therapy. (1984) (13)
- Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial. (1984) (13)
- Changes of the spontaneous cytotoxicity of the blood lymphocyte population following local radiation therapy for breast cancer. (1982) (13)
- Subpopulations of Cells Involved in the Human Mixed Lymphocyte Culture Response (1977) (13)
- Incidence of infectious symptoms after radiation therapy for breast cancer. Long-term effects. (1987) (12)
- Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study. (1980) (12)
- Bestatin treatment enhances the recovery of radiation induced impairments of the immunological reactivity of the blood lymphocyte population in bladder cancer patients. (1986) (12)
- Release of mitogenic factor by mouse lymph node cells stimulated with PHA in vitro. Inhibition of this phenomenon by the addition of thymocytes. (1975) (12)
- Capacity of C3H X CBA spleen cells to depress the MLC response of CBA mice specifically. Evidence for an active role of the injected cells. (1976) (12)
- Interaction between thymocytes and lymph-node cells in the graft-versus-host response: evidence for a synergistic and an antagonistic activity mediated by mouse thymocytes. (1974) (12)
- Bestatin, a new immunomodulator, augments the release of mitogenic factors from PHA-stimulated human lymphocytes. (1981) (12)
- Reappearance and relative importance of immunocompetent cells in the thymus, spleen and lymph nodes following lethal x-irradiation and bone marrow reconstitution in mice. (1971) (12)
- Treatment of patients with disseminated colorectal cancer with recombinant human alpha2‐interferon. Studies on the immune system (1984) (12)
- Effect of radiotherapy on lymphocyte cytotoxicity in vitro. (1975) (11)
- Influence of adjuvant tamoxifen on blood lymphocytes (1988) (11)
- Evidence for the appearance of non-specific inhibitor cells in the blood after radiation therapy for breast carcinoma (1977) (11)
- Influence of interferon on poke weed mitogen triggered Ig-secretion by human lymphocytes in vitro. (1981) (11)
- Weak Graft‐Versus‐Host Response of CBA Lymphocytes Against the H‐2‐Identical Strain C3H (1974) (11)
- In vitro capacity of various cyclooxygenase inhibitors to revert immune suppression caused by radiation therapy for breast cancer. (1990) (11)
- Influence of adjuvant chemotherapy on the blood lymphocyte population in operable breast carcinoma. Comparison between two types of treatments. (1982) (10)
- THE ROLE OF BONE MARROW OF X‐IRRADIATED MICE IN THYMIC RECOVERY (1971) (10)
- Long-term effects on the immune system following local irradiation for breast cancer. Pokeweed mitogen induced immunoglobulin secretion by blood lymphocytes and serum immunoglobulin levels. (1985) (10)
- Enhancement of the mixed lymphocyte response in the mouse by addition of thymocytes. (1974) (10)
- Effect of radiation therapy on the mitogenic response of in vitro irradiated human lymphocytes to phytohaemagglutinin. (1977) (10)
- Influence of adjuvant radiation therapy in breast cancer on PWM induced Ig-secretion by blood lymphocytes in vitro. (1983) (10)
- Reduced Capacity to Produce Specific ‘Effector’ Cells after Injection of CBA Mice with C3H Cells (1975) (10)
- Adjuvant radiation therapy compared with cyclic chemotherapy in patients with mammary carcinoma. I. Changes of blood lymphocyte subpopulations. (1981) (10)
- Bestatin treatment of human lymphocytes increases the frequency of sheep red blood cell-binding cells. (1981) (10)
- Lymphoid cells in carcinoma of the breast. Failure of response to phytohaemagglutinin in vitro. (1973) (9)
- Bestatin, a new immunomodulator, enhances migration and phagocytosis of human granulocytes in vitro. (1981) (9)
- Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes. (1979) (9)
- Lymphocyte counts and responses to PHA and PPD following radiation therapy for breast cancer in patients who develop recurrent disease and those who remain clinically disease-free. (1980) (9)
- T-cell subsets in patients treated with pelvic irradiation for cancer. (1985) (9)
- Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity. (1983) (9)
- Regulation of lymphocyte proliferation by soluble products released by stimulated human lymphocytes. (1978) (8)
- Prognostic relevance of postirradiation lymphocyte reactivity in breast cancer patients (1986) (8)
- Augmentation of spontaneous cytotoxicity of human lymphocytes by RU 41.740 is due to monocyte-derived factors distinct from interleukin 2, interferon alpha and gamma. (1987) (8)
- Antibody Response in C3H Mice Injected with CBA Lymphoid Cells As Detected by Membrane Immunofluorescent Staining (1975) (8)
- Depressed responder and stimulator capacities of peripheral lymphocytes from patients with advanced breast cancer in the mixed lymphocyte culture. (1977) (8)
- Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response modifiers. (1985) (8)
- Prognistic relevance of radiation induced immune suppression in breast carcinoma. (1979) (8)
- Modulation of lymphocyte and monocyte responses in vitro by 9-deoxy-delta 9-prostaglandin D2 and 9-deoxy-delta 9-delta 12-prostaglandin D2. (1988) (8)
- Does informed adjuvant placebo chemotherapy for breast-cancer elicit immune changes. (1994) (8)
- Antiestrogen effects on human blood lymphocyte subpopulations in vitro. (1985) (8)
- The extent of specific adsorption of cytotoxic educated thymus cells: evolution with time and number of injected cells. (1973) (8)
- Studies on the recirculating cells in the mouse thymus. (1972) (7)
- Loss of graft-versus-host reactivity of mouse lymphocytes during serial passage through irradiated allogeneic hosts. (1973) (7)
- The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from patients with untreated and cured Hodgkin's disease (1980) (7)
- Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer. (1986) (7)
- ENHANCED NK ACTIVITY IN PATIENTS TREATED BY INTERFERON-α. RELATION TO CLINICAL RESPONSE (1982) (7)
- Inhibition of erythropoiesis in the spleens of irradiated mice injected with allogeneic lymphocytes. Reactivity of lymphocytes aganist non-H-2 transplantation antigens. (1973) (7)
- Natural killer activity of blood lymphocytes in patients with primary intracranial tumors. Correlation to histological tumor type and anatomical site. (1986) (7)
- Evidence that nonspecific inhibitors are induced by soluble products of activated human lymphocytes. (1978) (7)
- Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type. (1985) (7)
- Bestatin, a new immunomodulator (1983) (6)
- Influence of Bestatin, a new immunomodulator, on Ig secretion by human lymphocytes in vitro and in vivo. (1981) (6)
- Changes of the "radioresistant" thymic lymphocyte population following x-irradiation of mice. (1970) (6)
- Radiotherapy and persistent reduction of peripheral T cells. (1983) (6)
- DNA‐Synthetic Responses of Fractionated Human Lymphocytes Exposed to Lymphocyte‐Derived Mitogenic Factor (1976) (6)
- Bestatin treatment for the correction of granulocyte dysfunction in patients with recurrent furunculosis (1983) (6)
- Thyroid hormones and lymphoid cells. (1975) (6)
- How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer (1995) (6)
- In vitro radiosensitivity of the spontaneous cytotoxicity of blood lymphocytes in patients with untreated Hodgkin's disease. (1983) (6)
- The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease (1979) (6)
- Oral treatment with RU 41.740 (Biostim) in patients with advanced colorectal cancer: influence on the blood lymphocyte population. (1989) (6)
- Proliferation of peripheral lymphoid cells from euthyroid and hyperthyroid individuals cultured with human thyroglobulin. (1979) (6)
- Evidence of Different Cell Populations in the Mouse Thymus Releasing and Responding to Mitogenic Factor (1975) (6)
- Enrichment of PHA-responsive lymphocytes in chronic lymphocytic leukaemia after removal of Ig-bearing cells. (2009) (5)
- Effect of bleomycin on peripheral lymphocytes. (1977) (5)
- Cross-reactivity patterns of mouse lymphocytes sensitized against the major histocompatibility complex using a graft-versus-host assay. (1974) (5)
- Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells. (1989) (5)
- Induction of specific unresponsiveness against the C3H M1s=antigen in mice, increase of suppressive capacity of C3H X CBA F1-lymphocytes after sensitization against CBA lymphoid cells. (1978) (5)
- Changes of the blood lymphocyte subpopulations and their functions following 131I treatment for nodular goitre and 32P treatment for polycythemia vera. (1988) (5)
- Inhibition of erythroid cell growth by allogeneic murine lymphocytes. Evidence for a synergism between lymph node cells and thymocytes. (1974) (5)
- Increased reduction of nitroblue tetrazolium by human blood monocytes following post-operative radiation therapy for breast cancer. (1982) (5)
- Proportion of lymphocytes forming E, EA, and EAC rosettes following treatment with human interferon preparations in vitro. (1980) (5)
- Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. Its potential use in the treatment of superficial bladder cancer. (1991) (5)
- Thymidylate synthase expression in rectal cancer and proliferation, assessed by cyclin A and Ki-67 expression. (2002) (5)
- Changes of blood T cell subsets in patients receiving postoperative adjuvant chemotherapy for breast cancer. (1984) (5)
- Disease-related lymphocyte cytotoxicity in vitro in patients with transitional cell carcinoma of the urinary bladder. Comparisons with other malignancies, acute cystitis, and healthy donors (1980) (5)
- Changes of the blood lymphocyte population following 131I treatment for nodular goiter. (1987) (5)
- Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue. (1977) (5)
- Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors (2011) (5)
- Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. (1990) (5)
- The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with hodgkin's disease and non‐hodgkin's lymphoma (1982) (5)
- Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder (1987) (4)
- Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer (1987) (4)
- Complex Nature of the Production of ‘Effector Cells and Their Interaction with Target Cells in the M‐Antigen System of the Mouse (1976) (4)
- Blood lymphocyte subsets in patients with primary intracranial tumours. Correlation to histological tumour type and anatomical site (2005) (4)
- Time factor in PHA responsiveness of human blood lymphocytes after in vitro irradiation. (1978) (4)
- Bestatin treatment and the peripheral lymphocyte population in cancer patients. (1980) (4)
- Influence of human interferon-α therapy on cytotoxic functions of blood lymphocytes (1983) (4)
- Long-term effects on the immune system following local radiation therapy for breast cancer. III. Changes of spontaneous and lectin dependent cellular cytotoxicity. (1986) (4)
- Effect of irradiation on Concanavalin A-induced suppression of mitogen responses in human lymphocyte cultures. (1982) (4)
- Influence of Bestatin, a new immunomodulator, on various functions of human monocytes. (1982) (4)
- Influence of RU 41.740 on human monocytes in vitro: release of soluble factors which retard multiplication of tumor cells in culture. (1990) (4)
- Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro. (1996) (4)
- T-cell dependency of the response to PVP is dependent on maturity of B-cells. (1976) (4)
- Synergistic enhancement of mitogen responses of human lymphocytes by inhibitors of cyclo-oxygenase and lipoxygenase. (1988) (4)
- Relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytes (2004) (4)
- The effect of some cytotoxic agents on lymphocyte subpopulations in vitro. (1980) (4)
- F1‐Hybrid Anti‐Parental‐Strain Reactivity (1978) (4)
- Prognostic relevance of postirradiation lymphocyte reactivity in breast cancer patients. (1986) (4)
- RADIOTHERAPY, IMMUNOREACTIVITY, AND RECURRENCE OF BREAST CANCER (1980) (4)
- Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinoma. (1990) (4)
- Augmentation of spontaneous cytotoxicity of human lymphocytes by RU 41.740, a glucoprotein extract of Klebsiella pneumoniae. (1987) (4)
- Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer (1986) (4)
- Blood lymphocyte population following 131I treatment for hyperthyroidism. (1991) (4)
- Characterization of lymphocytes which inhibit proliferation of human T cells exposed to lymphocyte-derived mitogenic factors. (1979) (4)
- Activation of monocytes in vitro to produce lymphocyte dysfunctions. (1979) (3)
- F1‐Hybrid Anti‐Parental‐Strain Reactivity I. Impaired Proliferation of CBA Lymphocytes in the Spleens of Irradiated C3H×CBA Mice Pretreated with CBA Spleen Cells (1978) (3)
- Enhancement of the human mixed lymphocyte culture response by pretreating the stimulating cells with interferon. (1980) (3)
- Possible role of acrolein in oxazaphosphorine-induced enhancement of immunological reactivity (2005) (3)
- Effect of estrogens on human blood lymphocyte subpopulations in vitro. (1984) (3)
- In vivo and in vitro selection of mitogen responsive lymphocytes in patients with chronic lymphocytic leukemia. (1976) (3)
- Human monocytes exposed to Biostim (RU 41740) alter lymphocyte mitogenesis: mechanisms of action. (1988) (3)
- Suppressor T cells in mycosis fungoides and so-called premycotic eruptions. (1980) (3)
- Adjuvant radiation therapy compared with cyclic chemotherapy in patients with mammary carcinoma. II. Changes of mitogen responses of blood lymphocytes. (1981) (3)
- Changes of MLC reactivity in lymphoid organs after injection of mice with H-2 disparate cells. (1975) (3)
- Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type. (1985) (3)
- Immunomodulation by bestatin in the human (1982) (2)
- IN VIVO ADMINISTRATION OF INTERFERON TO MAN: STUDIES ON THE IMMUNE SYSTEM. (1980) (2)
- Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsiveness. (2009) (2)
- Bleomycin treatment in a case of polyarteritis nodosa. Some immunological studies. (2009) (2)
- Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder — A summary (2004) (2)
- Prognostic value of various immunological tests in breast cancer patients treated with adjuvant postoperative chemotherapy. (1984) (2)
- Effect of human interferon on lectin-dependent cellular cytotoxicity. (1981) (2)
- Autonomy of the PHA-responsive cells in the mouse thymus. (2009) (2)
- Lymphopenia and breast metastasis. (1977) (2)
- Spontaneous cytotoxicity of blood lymphocytes following local radiation therapy for carcinoma of the urinary bladder. (1983) (2)
- Proliferation of C3H x CBA hybrid lymphocytes in the spleens of irradiated CBA mice: inhibition of this phenomenon by pretreatment of the hosts with C3H x CBA spleen cells. (1980) (2)
- Studies on the lymphatic system in longterm survivors treated for Wilms' tumour or non-Hodgkin's lymphoma during childhood. (1980) (2)
- Proliferation of C3HXCBA Hybrid Lymphocytes in the Spleens of Irradiated CBA Mice: Inhibition of this Phenomenon by Pretreatment of the Hosts with C3HXCBA Spleen Cells (1980) (2)
- Inhibition of tumor cell growth in vitro by 2-mercaptoethanesulfonate (mesna) and other thiols. (1991) (2)
- Capacity of sera from patients with mammary carcinoma to promote PHA-stimulation of human lymphocytes. (1975) (2)
- Impact of adjuvant chemotherapy on spontaneous and poke week mitogen triggered immunoglobulin secretion of blood lymphocytes in operable breast cancer. (1988) (2)
- Effect of 32P treatment for polycythaemia vera on blood lymphocyte subpopulations and their functions (1987) (2)
- Graft-versus-host response, measured by splenomegaly assay, by populations of allosensitized mouse lymphocytes. (1976) (2)
- Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes (2004) (1)
- Inhibition of erythroid cell growth in irradiated mice by allogeneic lymphoid cells: specificity of the response. (1976) (1)
- Effect of pepleomycin on peripheral lymphocytes. (1981) (1)
- Detection of Mls-antigens in various mouse strains using a new method (1976) (1)
- Evidence of Different Cell Populations in the Mouse Thymus Releasing and Responding to Mitogenic Factor (1975) (1)
- Activated mouse lymphocyte release factors which modulate the proliferative responses of other lymphocytes. (1977) (1)
- Influence of an M‐Locus Difference on the Cellular and Humoral Immunological Reactivity Against H‐2‐Determined Antigens of the Mouse (1977) (1)
- Radiosensitivity of Hodgkin's disease lymphocytes. (1981) (1)
- 1019 Extracranial stereotactic radiosurgery. Clinical results (1996) (1)
- Bestatin, a new immunomodulator. In vivo and n vitro studies in man (1980) (1)
- Blood lymphocyte subsets in operable breast-cancer - relation to extent of tumor disease and prognosis. (1993) (1)
- Capacity of C3H × CBA spleen cells to depress the MLC response of CBA mice specifically (1976) (1)
- 1028 Extracranial stereotactic radiosurgery — Method (1996) (1)
- Reduction of PWM-induced Ig secretion by blood lymphocytes following local radiation therapy for breast cancer. (1981) (1)
- The effect of radiation on T cell modulation of Ig synthesis by human B cells in vitro. (1983) (1)
- Changes of CD2 receptor density determined by electron microscopy on blood lymphocytes following radiation treatment for breast cancer. (1990) (1)
- Partial Tolerant State Against H‐2 Disparate Cells (1976) (1)
- Blood lymphocyte population 4 to 6 years after adjuvant cyclic chemotherapy for operable breast carcinoma. (1985) (0)
- Route of administration may determine the biological effects of RU 41,740 (Biostim). Trapping of 99mTc-labelled human albumin colloids in mice. (1993) (0)
- Influence of bleomycin and pepleomycin on mitogen stimulations of human lymphocytes in vitro. (1980) (0)
- Changes of the blood lymphocyte population following 32P treatment for polycythemia vera (1990) (0)
- Non-specific suppression of alloantibody responses of CBA mice injected with lymphoid cells from the MIs-antigen incompatible C3H X CBA hybrid. (1978) (0)
- Ru 41.740 triggers human mononuclear blood cells to release tumor growth inhibitory factors in vitro. (1992) (0)
- Brain tumors. (1996) (0)
- Melphalan treatment of human peripheral T cells promotes Ig production by B cells in vitro. (1985) (0)
- Search for specific effector functions of C3H X CBA lymphocytes which have proliferated in the spleens of irradiated CBA mice. (1979) (0)
- Rectal cancer. (1996) (0)
- How to optimize the effect of 5-fluorouracil therapy in advanced colorectal cancer modulated (0)
- Contents, Vol. 55, 1977 (1977) (0)
- Inhibition of erythroid cell growth by allogeneic Mis-antigen-sensitized lymphocytes: specificity of the reaction. (1977) (0)
- ON MATURITY OF B-CELLS (1976) (0)
- Book Review / News Item / Erratum (1987) (0)
- Long-term results after fractionated radiation therapy for large brain arteriovenous malformations. Commentary (2005) (0)
- APPENDIX – METHODS OF TESTING HUMAN IMMUNE RESPONSES (1981) (0)
- Humoral and Cellular Immune Response in Patients with Transitional Cell Carcinoma of the Urinary Bladder (TCC) Against Bladder Carcinoma Cells in Tissue Culture (1980) (0)
- Lymphocyte subpopulations and reactivity in breast cancer recurrence following adjuvant postoperative chemotherapy. (1984) (0)
This paper list is powered by the following services:
